Browsing by Keyword : Antineoplastic Agents, Immunological
Showing results 1 to 7 of 7
| Pub Year | | Title | Author(s) |
| 2022 | | A phase IA dose-escalation study of PHI-101, a new checkpoint kinase 2 inhibitor, for platinum-resistant recurrent ovarian cancer | 공태욱, 장석준 |
| 2021 | | Adaptive natural killer cells facilitate effector functions of daratumumab in multiple myeloma | 최윤석 |
| 2021 | | Determinants of response and intrinsic resistance to pd-1 blockade in microsatellite instability–high gastric cancer | 김규태 |
| 2020 | | Direct targeting of oncogenic RAS mutants with a tumor-specific cytosol-penetrating antibody inhibits RAS mutant-driven tumor growth | 이다근 |
| 2019 | | Involvement of p38 Activation and Mitochondria in Death of Human Leukemia Cells Induced by an Agonistic Human Monoclonal Antibody Fab Specific to TRAIL Receptor 1 | 장영주 |
| 2021 | | Trastuzumab-based palliative chemotherapy for HER2-positive gastric cancer: a single-center real-world data | 강석윤, 김태환, 신승수, 안미선, 이현우, 조헌도, 최용원, 최진혁 |
| 2020 | | Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13-01) | 최진혁 |
1
